Search results
DARZALEX® (daratumumab)-based regimens significantly improve clinical outcomes in both...
Valley City Times Record· 5 days agoJohnson & Johnson today announced data from the Phase 3 PERSEUS study showing deepening of responses...
These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
TipRanks via Yahoo Finance· 3 days agoThere are two sides to every coin. This holds particularly true for penny stocks, or tickers that...
Groundbreaking LLNL and BridgeBio Oncology Therape | Newswise
Newswise· 4 days agoIn a substantial milestone for supercomputing-aided drug design, Lawrence Livermore National...
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health...
Morningstar· 2 days agoSeres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it has entered into a non-binding memorandum of understanding with Nestlé Health Science ...
Three Indian CDMOs ready to seize the BIOSECURE Act opportunity
BioPharma-Reporter· 2 days agoSpearheading this effort is the BIOSECURE Act, a bipartisan initiative gaining traction in Congress...